Emergent BioSolutions Inc ER4-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 8:07 AM CEST
30.74quote price arrow up+0.01 (+0.03%)
52 week range
26.07 - 55.90
Loading...
  • Open30.74
  • Day High30.74
  • Day Low30.74
  • Prev Close28.82
  • 52 Week High55.90
  • 52 Week High Date07/22/21
  • 52 Week Low26.07
  • 52 Week Low Date06/17/22

Key Stats

  • Market Cap1,651.1M
  • Shares Out50.4M
  • 10 Day Average Volume910.09
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-23.38

KEY STATS

  • Open30.74
  • Day High30.74
  • Day Low30.74
  • Prev Close28.82
  • 52 Week High55.90
  • 52 Week High Date07/22/21
  • 52 Week Low26.07
  • 52 Week Low Date06/17/22
  • Market Cap1,651.1M
  • Shares Out50.4M
  • 10 Day Average Volume910.09
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-23.38

RATIOS/PROFITABILITY

  • EPS (TTM)2.66
  • P/E (TTM)11.56
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Emergent BioSolutions, Inc. is a life sciences company focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats (PHTs). The Company is focused on five PHT categories: chemical, biological, radiological, nuclear and explosives (CBRNE); emerging infectious diseases; travel health; public health crises (such as the opioid crisis and the COVID-19 pandemic); acute, emergency, and community care. Its...
Zsolt Harsanyi Ph.D.
Non-Executive Independent Chairman of the Board
Robert Kramer Sr.
President, Chief Executive Officer, Director
Adam Havey
Chief Operating Officer, Executive Vice President
Richard Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Address
2273 RESEARCH BLVD, SUITE 400
Rockville, MD
20850
United States